Overall survival is not a realistic end point for clinical trials of new drugs in advanced solid tumors: A critical assessment based on recently reported phase III trials in colorectal and breast cancer

被引：62

作者：

Di Leo, A ^{[1
]}

Bleiberg, H

Buyse, M

机构：

[1] Inst Jules Bordet, B-1000 Brussels, Belgium

[2] Int Inst Drug Dev, Cambridge, MA USA

来源：

JOURNAL OF CLINICAL ONCOLOGY | 2003年 / 21卷 / 10期

关键词：

D O I：

10.1200/JCO.2003.99.089

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：2045 / 2047

页数：3

共 14 条

[1] Doxorubicin and paclitaxel versus doxorubicin and cyclophosphamide as first-line chemotherapy in metastatic breast cancer: The European Organization for Research and Treatment of Cancer 10961 multicenter phase III trial [J].

Biganzoli, L ;

Cufer, T ;

Bruning, P ;

Coleman, R ;

Duchateau, L ;

Calvert, AH ;

Gamucci, T ;

Twelves, C ;

Fargeot, P ;

Epelbaum, R ;

Lohrisch, C ;

Piccart, MJ .

JOURNAL OF CLINICAL ONCOLOGY, 2002, 20 (14) :3114-3121

[2]

BONNETERRE J, 2001, P AN M AM SOC CLIN, V20, P42

[3]

CARMICHAEL J, 2001, P AN M AM SOC CLIN, V20, P22

[4] Leucovorin and fluorouracil with or without oxaliplatin as first-line treatment in advanced colorectal cancer [J].

de Gramont, A ;

Figer, A ;

Seymour, M ;

Homerin, M ;

Hmissi, A ;

Cassidy, J ;

Boni, C ;

Cortes-Funes, H ;

Cervantes, A ;

Freyer, G ;

Papamichael, D ;

Le Bail, N ;

Louvet, C ;

Hendler, D ;

de Braud, F ;

Wilson, C ;

Morvan, F ;

Bonetti, A .

JOURNAL OF CLINICAL ONCOLOGY, 2000, 18 (16) :2938-2947

[5] Irinotecan combined with fluorouracil compared with fluorouracil alone as first-line treatment for metastatic colorectal cancer: a multicentre randomised trial [J].

Douillard, JY ;

Cunningham, D ;

Roth, AD ;

Navarro, M ;

James, RD ;

Karasek, P ;

Jandik, P ;

Iveson, T ;

Carmichael, J ;

Alakl, M ;

Gruia, G ;

Awad, L ;

Rougier, P .

LANCET, 2000, 355 (9209) :1041-1047

[6]

*EUR AG EV MED PRO, NOT GUID EV ANT MED

[7] Phase III multicenter randomized trial of oxaliplatin added to chronomodulated fluorouracil-leucovorin as first-line treatment of metastatic colorectal cancer [J].

Giacchetti, S ;

Perpoint, B ;

Zidani, R ;

Le Bail, N ;

Faggiuolo, R ;

Focan, C ;

Chollet, P ;

Llory, JF ;

Letourneau, Y ;

Coudert, B ;

Bertheaut-Cvitkovic, F ;

Larregain-Fournier, D ;

Le Rol, A ;

Walter, S ;

Adam, R ;

Misset, JL ;

Lévi, F .

JOURNAL OF CLINICAL ONCOLOGY, 2000, 18 (01) :136-147

[8] Doxorubicin and paclitaxel versus fluorouracil, doxorubicin, and cyclophosphamide as first-line therapy for women with metastatic breast cancer: Final results of a randomized phase III multicenter trial [J].

Jassem, J ;

Pienkowski, T ;

Pluzanska, A ;

Jelic, S ;

Gorbunova, V ;

Mrsic-Krmpotic, Z ;

Berzins, J ;

Nagykalnai, T ;

Wigler, N ;

Renard, J ;

Munier, S ;

Weil, C .

JOURNAL OF CLINICAL ONCOLOGY, 2001, 19 (06) :1707-1715

[9]

LUCK HJ, 2000, P AN M AM SOC CLIN, V19, P73

[10]

MACKEY JR, 2002, P AN M AM SOC CLIN, V21, P35

← 1 2 →